lopinavir - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
KALETRA lopinavir 200mg and ritonavir 50mg tablets bottle
AUST R: 121055
Active ingredients:
lopinavir
ritonavir

Dosage form:
Tablet, film coated

Sponsor:
Abbvie Pty Ltd

Phone:
1800 252 224

Deletion from market:
14 Oct 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their health professional to discuss alternative treatment options.

KALETRA oral solution bottle
AUST R: 78627
Active ingredients:
lopinavir
ritonavir

Dosage form:
Oral Liquid, solution

Sponsor:
Abbvie Pty Ltd

Phone:
1800 252 224

Deletion from market:
14 Oct 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their health professional to discuss alternative treatment options.